Target cell specificity of a bacteriocin molecule: a C-terminal signal directs lysostaphin to the cell wall of Staphylococcus aureus
- PMID: 8890152
- PMCID: PMC452215
Target cell specificity of a bacteriocin molecule: a C-terminal signal directs lysostaphin to the cell wall of Staphylococcus aureus
Abstract
Microbial organisms secrete antibiotics that cause the selective destruction of specific target cells. Although the mode of action is known for many antibiotics, the mechanisms by which these molecules are directed specifically to their target cells hitherto have not been described. Staphylococcus simulans secretes lysostaphin, a bacteriolytic enzyme that cleaves staphylococcal peptidoglycans in general but that is directed specifically to Staphylococcus aureus target cells. The sequence element sufficient for the binding of the bacteriocin as well as of hybrid indicator proteins to the cell wall of S.aureus consisted of 92 C-terminal lysostaphin residues. Targeting to the cell wall of S.aureus occurred either when the hybrid indicator molecules were added externally to the bacteria or when they were synthesized and exported from their cytoplasm by an N-terminal leader peptide. A lysostaphin molecule lacking the C-terminal targeting signal was enzymatically active but had lost its ability to distinguish between S.aureus and S.simulans cells, indicating that this domain functions to confer target cell specificity to the bacteriolytic molecule.
Similar articles
-
Cross-linked peptidoglycan mediates lysostaphin binding to the cell wall envelope of Staphylococcus aureus.J Bacteriol. 2006 Apr;188(7):2463-72. doi: 10.1128/JB.188.7.2463-2472.2006. J Bacteriol. 2006. PMID: 16547033 Free PMC article.
-
Staphylococcus aureus mutants with increased lysostaphin resistance.J Bacteriol. 2006 Sep;188(17):6286-97. doi: 10.1128/JB.00457-06. J Bacteriol. 2006. PMID: 16923896 Free PMC article.
-
Cytoplasmic expression of mature glycylglycine endopeptidase lysostaphin with an amino terminal hexa-histidine in a soluble and catalytically active form in Escherichia coli.Protein Expr Purif. 2006 Jan;45(1):206-15. doi: 10.1016/j.pep.2005.07.025. Epub 2005 Aug 19. Protein Expr Purif. 2006. PMID: 16181789
-
Lysostaphin: Engineering and Potentiation toward Better Applications.J Agric Food Chem. 2022 Sep 21;70(37):11441-11457. doi: 10.1021/acs.jafc.2c03459. Epub 2022 Sep 9. J Agric Food Chem. 2022. PMID: 36082619 Review.
-
Lysostaphin: an antistaphylococcal agent.Appl Microbiol Biotechnol. 2008 Sep;80(4):555-61. doi: 10.1007/s00253-008-1579-y. Epub 2008 Jul 8. Appl Microbiol Biotechnol. 2008. PMID: 18607587 Review.
Cited by
-
Staphylococcus haemolyticus prophage ΦSH2 endolysin relies on cysteine, histidine-dependent amidohydrolases/peptidases activity for lysis 'from without'.J Biotechnol. 2012 Dec 31;162(2-3):289-98. doi: 10.1016/j.jbiotec.2012.09.010. Epub 2012 Sep 28. J Biotechnol. 2012. PMID: 23026556 Free PMC article.
-
Lysostaphin: A Staphylococcal Bacteriolysin with Potential Clinical Applications.Pharmaceuticals (Basel). 2010 Apr 19;3(4):1139-1161. doi: 10.3390/ph3041139. Pharmaceuticals (Basel). 2010. PMID: 27713293 Free PMC article. Review.
-
Evidence for a holin-like protein gene fully embedded out of frame in the endolysin gene of Staphylococcus aureus bacteriophage 187.J Bacteriol. 1999 Aug;181(15):4452-60. doi: 10.1128/JB.181.15.4452-4460.1999. J Bacteriol. 1999. PMID: 10419939 Free PMC article.
-
Characterization of the Lytic Capability of a LysK-Like Endolysin, Lys-phiSA012, Derived from a Polyvalent Staphylococcus aureus Bacteriophage.Pharmaceuticals (Basel). 2018 Feb 24;11(1):25. doi: 10.3390/ph11010025. Pharmaceuticals (Basel). 2018. PMID: 29495305 Free PMC article.
-
One fold, many functions-M23 family of peptidoglycan hydrolases.Front Microbiol. 2022 Oct 21;13:1036964. doi: 10.3389/fmicb.2022.1036964. eCollection 2022. Front Microbiol. 2022. PMID: 36386627 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources